Halozyme Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.04.20	Biotech Stocks Facing FDA Decision In May 2020 (RTTNews)
05.11.19	FDA Says "Not Now AVEO", HALO Axes 160 Jobs, RDHL Gets Nod For H.pylori Drug (RTTNews)
13.09.19	Halozyme: Genentech Reports Positive Outcome From Phase III Study Using ENHANZE (RTTNews)
11.06.18	Halozyme President And Chief Executive Officer, Dr. Helen Torley Named EY Entrepreneur Of The Year 2018 San Diego (PR Newswire)
01.06.18	Halozyme Identifies Plasma Biomarkers As Potential Predictors Of Survival In Pancreatic Cancer (PR Newswire)
29.05.18	Halozyme Therapeutics To Participate In Upcoming Healthcare Conferences (PR Newswire)
21.05.18	Brendan W. Zahl, Executive Vice President at Community Banks of Colorado, elected Chair of the Colorado Bankers Association (PR Newswire)
10.05.18	Halozyme Reports First Quarter 2018 Results (PR Newswire)
20.04.18	Strategic Storage Trust II, Inc. Announces Increased Estimated Per Share Net Asset Value of $10.65 (PR Newswire)
10.04.18	Halozyme To Host First Quarter 2018 Financial Results Conference Call (PR Newswire)
22.03.18	Halozyme Announces Nomination Of Directors For Reelection At 2018 Stockholder Meeting (PR Newswire)
14.03.18	Halozyme To Present Data From Six Nonclinical Studies At American Association Of Cancer Research Annual Conference (PR Newswire)
02.03.18	Ur-Energy Releases 2017 Year End Results (PR Newswire)
27.02.18	Halozyme Therapeutics To Present At Upcoming Healthcare Conference (PR Newswire)
23.02.18	Digital Advertising Blockchain XCHNG Demonstrates 180,000 Transactions Per Second And Adds Ad Veteran Mark Connon To Advisory Board (PR Newswire)
20.02.18	Halozyme Reports Fourth Quarter And Full-Year 2017 Results (PR Newswire)
22.01.18	Halozyme To Host Fourth Quarter And Full-Year 2017 Financial Results Conference Call (PR Newswire)
17.01.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Halozyme Therapeutics, Inc. (HALO) (PR Newswire)
17.01.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. - HALO (PR Newswire)
10.01.18	LPCN Awaits FDA Panel Vote Today, APHB Slumps, BGNE Crosses $100 Again (RTTNews)
10.01.18	Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018 (PR Newswire)
07.12.17	Alexion Gains Access To ENHANZE Technology; Halozyme To Receive $40 Mln Payment (RTTNews)
15.11.17	Halozyme Therapeutics To Participate In Upcoming Healthcare Conferences (PR Newswire)
10.11.17	Halozyme To Present Nonclinical Data At SITC 2017 Supporting Combination Of PEGPH20 With Checkpoint Inhibitors (PR Newswire)
09.11.17	DEPO Building New Specialty Business, FPRX Rebounds, HALO Glows (RTTNews)
07.11.17	Halozyme Reports Third Quarter 2017 Results (PR Newswire)
01.11.17	AZN Gets Speedy Nod, RBP-6000 Just One Step Away From Approval, STML Soars (RTTNews)
31.10.17	Phase 3 Study Of Subcutanous Daratumumab Initiated Using Halozyme's ENHANZE Technology (PR Newswire)
24.10.17	First Gastric Cancer Patient Dosed In Clinical Trial Collaboration Evaluating Halozyme's PEGPH20 In Combination With Anti-PDL1 Immunotherapy (PR Newswire)
16.10.17	Halozyme Initiates Clinical Trial Of PEGPH20 With Anti-PDL1 Immunotherapy In Cholangiocarcinoma And Gallbladder Cancer Patients (PR Newswire)
10.10.17	Halozyme to Host Third Quarter 2017 Financial Results Conference Call (PR Newswire)
28.09.17	HaloSource Launches Drinking Water Purification Products In India Under The astrea® Brand (PR Newswire)
25.09.17	Cyxtera Launches Global Channel Partner Program (PR Newswire)
18.09.17	Keep An Eye On These Biotech Stocks This Month, If Invested (RTTNews)
15.09.17	FinancialInsiders.com Earnings Recap Week Ending September 15th, 2017 (PR Newswire)
15.09.17	HALO Just Got Brighter - What Other Pharma Stocks Made News This Week? (RTTNews)
14.09.17	Halozyme Pulls Back Off Best Levels But Remains Sharply Higher (RTTNews)
14.09.17	Bristol-Myers Partners With Halozyme; Gains Access To ENHANZE Technology (RTTNews)
14.09.17	Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties (PR Newswire)
14.09.17	Halozyme Increases 2017 Financial Guidance (PR Newswire)
11.09.17	Qualcomm and Nokia to Collaborate on Driving Wide-Scale Mobile 5G NR Deployments to Meet Growing Market Demand (PR Newswire)
01.09.17	Technical Insights on Biotech Stocks -- Grifols, Halozyme Therapeutics, Illumina, and VIVUS (PR Newswire)
25.08.17	Halozyme Therapeutics To Present At Upcoming Healthcare Conferences (PR Newswire)
08.08.17	Halozyme Reports Second Quarter 2017 Results (PR Newswire)
04.08.17	Halozyme Therapeutics To Present At Upcoming Healthcare Conference (PR Newswire)
19.07.17	HaloSource Secures $2.2 Million in Funding to Accelerate Drinking Water Market Presence (PR Newswire)
13.07.17	Initiation Of Clinical Trial Collaboration Evaluating Halozyme's PEGPH20 In Combination With Anti-PDL1 Immunotherapy (PR Newswire)
10.07.17	Halozyme To Host Second Quarter 2017 Financial Results Conference Call (PR Newswire)
22.06.17	FDA Approves Genentech's RITUXAN HYCELA, A Subcutaneous Rituximab Coformulated With Halozyme ENHANZE Technology (PR Newswire)
04.06.17	Halozyme Phase 2 Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Halozyme Therapeutics Inc.

Aktien Top/Flop

Meistgelesene Nachrichten